Under these conditions, no significant changes in the MMP2 expression were observed in the modified HCC cells interfered with shRNA-CD151 or shRNA-integrin β1, compared to parental cells (Fig. 3D). The gene discussed is CD151; the disease is hepatocellular carcinoma.